The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease

As therapeutic trials target early stages of Parkinson’s disease (PD), appropriate patient selection based purely on clinical criteria poses significant challenges. Members of the Critical Path for Parkinson’s Consortium formally submitted documentation to the European Medicines Agency (EMA) support...

Descripció completa

Dades bibliogràfiques

Autors principals:	Diane Stephenson, Derek Hill, Jesse M. Cedarbaum, Maria Tome, Spiros Vamvakas, Klaus Romero, Daniela J. Conrado, David T. Dexter, John Seibyl, Danna Jennings, Timothy Nicholas, Dawn Matthews, Zhiyong Xie, Syed Imam, Paul Maguire, David Russell, Mark Forrest Gordon, Glenn T. Stebbins, Ed Somer, Jill Gallagher, Arthur Roach, Peter Basseches, Donald Grosset, Kenneth Marek
Format:	Artigo
Idioma:	Inglês
Publicat:	SAGE Publishing 2019-07-01
Col·lecció:	Journal of Parkinson’s Disease
Accés en línia:	https://doi.org/10.3233/JPD-191648
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!